DanCann Pharma A/S
- a biopharmaceutical company powered by cannabinoids
Founded 2018
Denmark
11 employees
Post Ipo Equity
Total: $35.61M
Biotechnology, Health and Wellness +2
Denmark
11 employees
Post Ipo Equity
Total: $35.61M
Biotechnology, Health and Wellness +2
General Information
Get notified when DanCann Pharma A/S moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track DanCann Pharma A/S
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Denmark Market
Biotechnology
About DanCann Pharma A/S
Taxonomy: biopharmaceutical, cannabinoids, pharmaceutical research, medical cannabis
Funding Rounds & Investors (5)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post-IPO Equity | •••••• | - | 27 Jun 2024 | |
| Post-IPO Equity | •••••• | - | 28 Nov 2023 | |
| Post-IPO Equity | •••••• | - | 04 Oct 2023 | |
| Post-IPO Debt | •••••• | 1 |
|
02 Jun 2023 |
| Post-IPO Equity | •••••• | - | 16 May 2023 |
FAQ About DanCann Pharma A/S
- a biopharmaceutical company powered by cannabinoids
DanCann Pharma A/S was founded in 2018.
DanCann Pharma A/S is headquartered in Denmark.
DanCann Pharma A/S operates in the following industries: Biotechnology, Health and Wellness, Manufacturing, Pharmaceutical.
DanCann Pharma A/S has approximately 11 employees.
DanCann Pharma A/S has completed 5 funding rounds, raising a total of $35.61M. The latest funding stage is Post Ipo Equity.
We're actively collecting intelligence on DanCann Pharma A/S.
Track DanCann Pharma A/S to get notifiedDon't just browse. Track.
Signal Tracker monitors DanCann Pharma A/S and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.